Long COVID immunity and imaging study
Part of Infections, Lungs & breathing clinical trials.
This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had COVID-19 at least 3 months ago.
- You either have ongoing symptoms (long COVID) or you fully recovered without lasting issues.
- You do not have a history of chronic fatigue syndrome before or after COVID.
- You have no history of serious psychiatric illness.
- You were never in the ICU or on a breathing machine for COVID.
- You are covered by French social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long “long COVID” affects children over time. It may help doctors better understand what symptoms last and what support could improve recovery.
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
This study looks at brain and nerve problems in children and teens who had COVID-19. It uses brain scans and other tests to understand long-lasting symptoms like headaches, tiredness, memory issues, or dizziness.
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
This study looks at how people recover from COVID-19 over time, including those with ongoing symptoms (Long COVID). It involves phone interviews and possibly in-person evaluations to understand long-term effects.
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Hear when a new COVID Long-Haul trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.